Quantcast

Latest Bioinformatics Stories

2014-10-01 08:30:43

Licensing Enables Protein Metrics to Expand its Analysis Portfolio into Lipidomics with a Novel Software Tool for Tandem Mass Spectrometry Data named Lipify(TM) SAN CARLOS, Calif., Oct. 1, 2014 /PRNewswire-iReach/ -- Protein Metrics, Inc., a leading provider of software for rapid and thorough protein and peptide characterization, today announced an agreement with Pacific Northwest National Laboratory (PNNL) whereby it was granted an exclusive commercial license to PNNL's lipid...

2014-10-01 08:30:36

Leading personal genetics company now offers both health and ancestry information exclusively to Canadians as part of 23andMe's Personal Genome Service(®) MOUNTAIN VIEW, CA, Oct. 1, 2014 /CNW/ - 23andMe, the leading personal genetics company, today announced it now offers both health and ancestry information exclusively to Canadians through the company's Personal Genome Service(®). 23andMe's Canadian customers can now access their own genetic information to better understand their...

2014-10-01 08:24:03

Rapid, Robust and Secure Technology Is Key for Genomics at Scale SAN DIEGO, Oct. 1, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today the appointment of J. Patrick Ravenel as chief technology officer. Ravenel has more than 20 years of enterprise software and systems experience and a proven track record of designing and architecting solutions for Fortune 500 companies. "Patrick has been recognized as a top designer and architect of...

2014-09-30 08:29:03

NEW YORK, Sept. 30, 2014 /PRNewswire/ -- Proteomics is a focus point for investment and collaboration, according to a new report from Kalorama Information. The healthcare market research publisher said that over 100 deals had occurred in proteomics in the past two years. The activity ranges from investments and IPOs, to agreements between private proteomic companies and academic institutions, to deals between pharma and biotech companies with novel proteomics innovator companies. Kalorama...

2014-09-29 23:04:10

Webinar on October 2nd 2014 will focus on Qlucore’s visualization-based software (PRWEB) September 29, 2014 Within the field of bioinformatics, biomedical scientists and organizations struggle with multiple challenges such as how to allow biomedical scientists to analyze data by themselves and how to utilize resources in an optimal way. Qlucore, provider of the bioinformatics software program Qlucore Omics Explorer, has developed a new educational webinar to address these challenges...

2014-09-29 12:30:20

Databiology's Information Management Platform Uses Annotation and Interpretation from Tute Genomics to Accelerate Cancer Genomics Research SAN FRANCISCO, Sept. 29, 2014 /PRNewswire-iReach/ -- Databiology Inc., a global life sciences software and services company, announced today that the genetic variant knowledge-base and genome interpretation capabilities of Tute Genomics Inc., a cloud-based software provider of genome annotation & clinical reporting, are now fully integrated...

2014-09-26 16:23:31

DALLAS, September 26, 2014 /PRNewswire/ -- According to the new market research report "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019", published by MarketsandMarkets, the global Transcriptomics Market is estimated to be worth $1985.5 Million by the end of 2014 and is expected to...

2014-09-25 16:24:46

LONDON, Sept. 25, 2014 /PRNewswire/ -- The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. Our report entitled "US Personalized Cancer Genome Sequencing Market" takes into account the Whole-Genome Sequencing services, which is one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment.In order to properly analyze the...

2014-09-25 12:27:54

NEW YORK, Sept. 25, 2014 /PRNewswire/ -- The market for "proteomics" instruments, reagents and testing for research and diagnostic applications topped 5 billion dollars in 2013, and should see rapid revenue growth, according to Kalorama information. The healthcare market research publisher said demand for better understanding of proteins and a desire for new therapies is expected to continue to grow the proteomics market rapidly, despite cost pressures generally in research. The...

2014-09-24 23:07:36

Omixon collaborates with G3 and Genomics England to HLA genotype 340 individuals by three different methods in a bid to demonstrate equivalency among WGS approaches, best in class targeted approaches (Holotype HLA) and legacy methods (Sanger SBT) Budapest, Hungary; Cambridge, MA & Richmond, VA (PRWEB) September 24, 2014 Global biotechnology company Omixon, headquartered in Budapest with US offices in Cambridge, MA, has announced a collaboration with Global Genomics Group (G3) to...


Latest Bioinformatics Reference Libraries

American Journal of Translational Research
2012-05-07 07:59:00

The American Journal of Translational Research is an open-access peer-reviewed medical journal published by the e-Century Publishing Corporation. The journal was established in 2009 and is considered one of the major journals on translational medical research. As of May 2012, the editor-in-chief is Wen-Hwa Lee (University of California, Irvine). The journal is intended to provide barrier-free forum for rapid dissemination of novel discoveries in translational research of medical science...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related